Literature DB >> 22102705

Ten novel mutations in the erythroid transcription factor KLF1 gene associated with increased fetal hemoglobin levels in adults.

Alice E Gallienne1, Hélène M P Dréau, Anna Schuh, John M Old, Shirley Henderson.   

Abstract

We investigated whether mutations in the KLF1 gene are associated with increased Hb F levels in ethnically diverse patients referred to our laboratory for hemoglobinopathy investigation. Functionally effective KLF1 mutations were identified in 11 out of 131 adult samples with an elevated Hb F level (1.5-25.0%). Eleven different mutations were identified, 9 of which were previously unreported. KLF1 mutations were not identified in a matched cohort of 121 samples with normal Hb F levels (<1.0%). A further novel KLF1 mutation was also found in a sickle cell disease patient with a Hb F level of 20.3% who had a particularly mild phenotype. Our results indicate KLF1 mutations could make a significant contribution to Hb F variance in malarial regions where hemogobinopathies are common. All the mutations identified were heterozygous providing further in vivo evidence that a single altered KLF1 allele is sufficient to increase Hb F levels.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22102705      PMCID: PMC3291586          DOI: 10.3324/haematol.2011.055442

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  24 in total

1.  Compound heterozygosity for KLF1 mutations associated with remarkable increase of fetal hemoglobin and red cell protoporphyrin.

Authors:  Stefania Satta; Lucia Perseu; Paolo Moi; Isadora Asunis; Annalisa Cabriolu; Liliana Maccioni; Franca Rosa Demartis; Laura Manunza; Antonio Cao; Renzo Galanello
Journal:  Haematologica       Date:  2011-01-27       Impact factor: 9.941

2.  KLF1 regulates BCL11A expression and gamma- to beta-globin gene switching.

Authors:  Dewang Zhou; Kaimao Liu; Chiao-Wang Sun; Kevin M Pawlik; Tim M Townes
Journal:  Nat Genet       Date:  2010-08-01       Impact factor: 38.330

3.  HbVar database of human hemoglobin variants and thalassemia mutations: 2007 update.

Authors:  Belinda Giardine; Sjozef van Baal; Polynikis Kaimakis; Cathy Riemer; Webb Miller; Maria Samara; Panagoula Kollia; Nicholas P Anagnou; David H K Chui; Henri Wajcman; Ross C Hardison; George P Patrinos
Journal:  Hum Mutat       Date:  2007-02       Impact factor: 4.878

Review 4.  Control of fetal hemoglobin: new insights emerging from genomics and clinical implications.

Authors:  Swee Lay Thein; Stephan Menzel; Mark Lathrop; Chad Garner
Journal:  Hum Mol Genet       Date:  2009-10-15       Impact factor: 6.150

5.  Mutation in erythroid specific transcription factor KLF1 causes Hereditary Spherocytosis in the Nan hemolytic anemia mouse model.

Authors:  Daniel P Heruth; Troy Hawkins; Derek P Logsdon; Margaret I Gibson; Inna V Sokolovsky; Ndona N Nsumu; Stephanie L Major; Barbara Fegley; Gerald M Woods; Karen B Lewing; Kathleen A Neville; Kenneth Cornetta; Kenneth R Peterson; Robert A White
Journal:  Genomics       Date:  2010-08-05       Impact factor: 5.736

6.  Multiplex ligation-dependent probe amplification identification of 17 different beta-globin gene deletions (including four novel mutations) in the UK population.

Authors:  Alice E Gallienne; Hélène M Dréau; Janice McCarthy; Adele T Timbs; Janet M Hampson; Anna Schuh; John M Old; Shirley J Henderson
Journal:  Hemoglobin       Date:  2009       Impact factor: 0.849

7.  Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin.

Authors:  Joseph Borg; Petros Papadopoulos; Marianthi Georgitsi; Laura Gutiérrez; Godfrey Grech; Pavlos Fanis; Marios Phylactides; Annemieke J M H Verkerk; Peter J van der Spek; Christian A Scerri; Wilhelmina Cassar; Ruth Galdies; Wilfred van Ijcken; Zeliha Ozgür; Nynke Gillemans; Jun Hou; Marisa Bugeja; Frank G Grosveld; Marieke von Lindern; Alex E Felice; George P Patrinos; Sjaak Philipsen
Journal:  Nat Genet       Date:  2010-08-01       Impact factor: 38.330

8.  Mutations in EKLF/KLF1 form the molecular basis of the rare blood group In(Lu) phenotype.

Authors:  Belinda K Singleton; Nicholas M Burton; Carole Green; R Leo Brady; David J Anstee
Journal:  Blood       Date:  2008-05-16       Impact factor: 22.113

9.  A dominant mutation in the gene encoding the erythroid transcription factor KLF1 causes a congenital dyserythropoietic anemia.

Authors:  Lionel Arnaud; Carole Saison; Virginie Helias; Nicole Lucien; Dominique Steschenko; Marie-Catherine Giarratana; Claude Prehu; Bernard Foliguet; Lory Montout; Alexandre G de Brevern; Alain Francina; Pierre Ripoche; Odile Fenneteau; Lydie Da Costa; Thierry Peyrard; Gail Coghlan; Niels Illum; Henrik Birgens; Hannah Tamary; Achille Iolascon; Jean Delaunay; Gil Tchernia; Jean-Pierre Cartron
Journal:  Am J Hum Genet       Date:  2010-11-04       Impact factor: 11.025

10.  Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults.

Authors:  Swee Lay Thein; Stephan Menzel; Xu Peng; Steve Best; Jie Jiang; James Close; Nicholas Silver; Ageliki Gerovasilli; Chen Ping; Masao Yamaguchi; Karin Wahlberg; Pinar Ulug; Tim D Spector; Chad Garner; Fumihiko Matsuda; Martin Farrall; Mark Lathrop
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-25       Impact factor: 11.205

View more
  22 in total

1.  Using the hemoglobin switch for the treatment of sickle cell disease.

Authors:  Jan Cools
Journal:  Haematologica       Date:  2012-02       Impact factor: 9.941

Review 2.  Cell signaling pathways involved in drug-mediated fetal hemoglobin induction: Strategies to treat sickle cell disease.

Authors:  Betty S Pace; Li Liu; Biaoru Li; Levi H Makala
Journal:  Exp Biol Med (Maywood)       Date:  2015-08

3.  The switch from fetal to adult hemoglobin.

Authors:  Vijay G Sankaran; Stuart H Orkin
Journal:  Cold Spring Harb Perspect Med       Date:  2013-01-01       Impact factor: 6.915

Review 4.  Erythropoiesis: development and differentiation.

Authors:  Elaine Dzierzak; Sjaak Philipsen
Journal:  Cold Spring Harb Perspect Med       Date:  2013-04-01       Impact factor: 6.915

5.  Compound heterozygosity for KLF1 mutations is associated with microcytic hypochromic anemia and increased fetal hemoglobin.

Authors:  Jiwei Huang; Xinhua Zhang; Dun Liu; Xiaofeng Wei; Xuan Shang; Fu Xiong; Lihua Yu; Xiaolin Yin; Xiangmin Xu
Journal:  Eur J Hum Genet       Date:  2015-01-14       Impact factor: 4.246

6.  Original Research: Stable expression of miR-34a mediates fetal hemoglobin induction in K562 cells.

Authors:  Christina M Ward; Biaoru Li; Betty S Pace
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-02

7.  Synergistic effect of two β globin gene cluster mutations leading to the hereditary persistence of fetal hemoglobin (HPFH) phenotype.

Authors:  Priya Hariharan; Madhavi Sawant; Manju Gorivale; Ruma Manchanda; Roshan Colah; K Ghosh; Anita Nadkarni
Journal:  Mol Biol Rep       Date:  2017-09-06       Impact factor: 2.316

Review 8.  EKLF/KLF1, a tissue-restricted integrator of transcriptional control, chromatin remodeling, and lineage determination.

Authors:  Yvette Y Yien; James J Bieker
Journal:  Mol Cell Biol       Date:  2012-10-22       Impact factor: 4.272

9.  Fetal hemoglobin in sickle cell anemia: genetic studies of the Arab-Indian haplotype.

Authors:  Duyen Ngo; Harold Bae; Martin H Steinberg; Paola Sebastiani; Nadia Solovieff; Clinton T Baldwin; Efthymia Melista; Surinder Safaya; Lindsay A Farrer; Ahmed M Al-Suliman; Waleed H Albuali; Muneer H Al Bagshi; Zaki Naserullah; Idowu Akinsheye; Patrick Gallagher; Hong-yuan Luo; David H K Chui; John J Farrell; Amein K Al-Ali; Abdulrahman Alsultan
Journal:  Blood Cells Mol Dis       Date:  2013-03-07       Impact factor: 3.039

10.  KLF1 mutations are relatively more common in a thalassemia endemic region and ameliorate the severity of β-thalassemia.

Authors:  Dun Liu; Xinhua Zhang; Lihua Yu; Ren Cai; Xiaoxia Ma; Chengguang Zheng; Yuqiu Zhou; Qiji Liu; Xiaofeng Wei; Li Lin; Tizhen Yan; Jiwei Huang; Narla Mohandas; Xiuli An; Xiangmin Xu
Journal:  Blood       Date:  2014-05-14       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.